Silence Therapeutics (SLN) Cost of Revenue (2024 - 2026)
Silence Therapeutics (SLN) posted Cost of Revenue of $11,000 for the quarter ended Mar 31, 2026, down 79.6% from $54,000 a year earlier and down 8.3% from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Cost of Revenue (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics' Cost of Revenue came in at $215,000, down 98.2% from the prior year.
- Annual Cost of Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -46.3% (years ended Dec 2020 to Dec 2025).
- In prior years, Silence Therapeutics' Cost of Revenue was $11.81 million in the year ended Dec 31, 2024 (-8.2%), $12.87 million in the year ended Dec 31, 2023 (-4.4%), $13.46 million in the year ended Dec 31, 2022 (+31.2%) and $10.26 million in the year ended Dec 31, 2021 (+112.4%).
- The figure for the quarter ended Mar 31, 2026 stands as the lowest quarterly Cost of Revenue in data going back to the quarter ended Mar 31, 2024.
- On a year-over-year basis, Cost of Revenue has declined in each of the last five quarters, with an average decline of 94.6% over the last five quarters.
- According to Business Quant data, Cost of Revenue for the three prior quarters was $12,000 (quarter ended Dec 31, 2025), $64,000 (quarter ended Sep 30, 2025) and $85,000 (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Silence Therapeutics | 502.70 Mn | 430.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 2.80 Mn |
API Access
Silence Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();